Substance use & recovery

Why Withdrawing From More Than One Substance Is Riskier

Save

Most people who use one substance regularly use another, often without thinking of it as a combination. That overlap is exactly what makes withdrawal harder to survive and harder to treat. This page explains why polysubstance withdrawal raises the medical stakes, why honesty about everything you use is the thing that keeps you safe, and how to get a real assessment before you stop.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

The short answer: risks compound and get harder to predict

When someone is dependent on more than one substance, withdrawal is riskier than for any single substance alone, for two reasons: the individual dangers stack, and the combined picture becomes harder to predict and to treat. A body adapted to two things is unwinding two adaptations at once, and the symptoms can overlap, mask one another, or hit at different times.

This is why polysubstance withdrawal is one of the clearest reasons a medical assessment matters. The plan for two substances is not the plan for one substance doubled. A clinician has to weigh which withdrawal is the dangerous one, which is merely miserable, and how they will interact, and that judgment cannot be made from a symptom list on a screen. The sections below explain where the specific dangers come from and what an honest assessment needs to catch them.

If alcohol or a sedative is in the mix, that is the part that can kill

The single most important thing about a combined withdrawal is whether alcohol or a sedative is one of the substances, because those are the withdrawals that can be fatal. Sedatives like benzodiazepines can cause life-threatening withdrawal, including seizures, even when the medicine was taken exactly as prescribed, which is why they require a gradual, patient-specific taper rather than an abrupt stop 1. Alcohol belongs on that short list of dangerous withdrawals too, and it is among the deadliest substances in the country by any measure, responsible for roughly 178,000 U.S. deaths each year 2.

When either is combined with an opioid, a stimulant, or a second sedative, the seizure risk does not go away, it gets easier to miss. Someone focused on the agony of opioid withdrawal may not realize that the daily drinking they barely mention is the part that can produce a seizure. If you want the detail on which withdrawals can actually kill you, or specifically on why benzodiazepine withdrawal is genuinely dangerous, those live on their own pages. Here the point is narrower: in any combination, find the alcohol or the sedative first, because that is where the lethal risk sits.

Why two withdrawals are not simply one plus one

Combined withdrawals interact, and that interaction is what makes them unpredictable. Two substances can pull the nervous system in opposite directions, so the calm that one withdrawal would produce is hidden by the agitation of another, and a dangerous sign gets buried. Symptoms can also arrive on different clocks: a stimulant crash lands within a day, while the most dangerous phase of alcohol withdrawal can be delayed, so the worst moment may come after someone assumes the hard part is over.

This staggering is the practical danger. A person riding out what feels like a manageable withdrawal from one drug can be blindsided by the delayed peak of another. It is also why quitting cold turkey is a poor frame for polysubstance use: stopping everything at once removes any ability to tell which withdrawal is causing which symptom, and for the dangerous substances an abrupt stop is the specific thing that triggers a seizure. Sorting that out in real time is what supervision is for.

The underreporting problem: a clinician can only manage what they are told

The most common way a combined withdrawal turns dangerous is that no one knew it was combined. People underreport what they have been using, sometimes out of shame, sometimes because a substance does not register as a drug in their mind: the nightly drinks, the borrowed sleeping pills, the daily cannabis, the kratom bought at a gas station. A clinician cannot weigh a risk they are not told about, so the fullest possible picture is what keeps a combined withdrawal from surprising everyone at the worst moment.

Being candid about every substance, including alcohol, prescriptions, and anything bought over the counter, is not a confession; it is the single most useful thing you can do to stay safe. You will not be judged for a complete list; you are protected by one. If a substance like kratom is part of the picture, its withdrawal has its own features worth naming to whoever assesses you, because it changes the plan. The safest assumption is that every substance counts, and the honest move is to name all of them up front.

The mental-health crash sits on top of the physical withdrawal

Polysubstance withdrawal is rarely only a physical event, and the psychological side can be the more dangerous one. Coming off stimulants brings a crash of exhaustion and low mood; coming off several things at once can deepen that into serious depression, hopelessness, or thoughts of self-harm, on top of whatever physical withdrawal is happening. Substance use disorders and other mental illnesses frequently co-occur, and the guidance is to treat both conditions together rather than one after the other 3.

That is another argument for assessment over solo detox. A withdrawal that is medically survivable can still be dangerous if it drops someone into a crisis with no support around them. When withdrawal brings hopelessness or thoughts of suicide, that is a reason to reach for help immediately, not to push through, and it is part of why matching the setting to the whole person, body and mind, is what a real evaluation does.

Treatment sequencing gets more complicated with more substances

More substances also complicate what comes after withdrawal, because the medications and the order they are started in depend on the full mix. Extended-release naltrexone, for example, cannot be started until opioid withdrawal is fully complete, which makes it harder to initiate than buprenorphine and causes more early failures when detox is rushed or incomplete; in a head-to-head trial both worked similarly well once successfully started, but the induction hurdle was real 4. When more than one substance is involved, getting that sequence right is harder and matters more.

This is where detox alone shows its limits. For opioids, medications like methadone and buprenorphine are the evidence-based standard of care and are not substituting one addiction for another; at therapeutic doses they reduce cravings and withdrawal without producing a high 5. A combined withdrawal handled without a plan for what follows leaves the hardest part, staying well afterward, entirely unaddressed, which is the opposite of what a good assessment sets up.

How to get assessed before you stop

Because a combined withdrawal is genuinely hard to judge from the inside, the safe move is an in-person assessment before stopping, not a guess. A clinician can sort which substance carries the lethal risk, which withdrawal will peak when, and whether the setting should be inpatient monitoring or something less intensive. That sorting is exactly what cannot be done from a web page, and it is the honest alternative to reading a symptom checklist and hoping.

To find that assessment without a sales pitch, FindTreatment.gov is the federal government's free, confidential, anonymous locator of state-licensed treatment facilities, a neutral route rather than a billboard 6. If a combined withdrawal is already producing a seizure, severe confusion, chest pain, or thoughts of self-harm, that is past the point of planning: it is an emergency, and knowing when to call 911 during withdrawal comes down to those signs. Withdrawal during pregnancy adds its own considerations and is another clear reason to be evaluated rather than to stop alone.

Common questions

The individual dangers stack and the combined picture becomes harder to predict. If alcohol or a sedative is in the mix, the fatal seizure risk from that substance remains, and a second drug can mask the warning signs or peak on a different schedule. A clinician has to weigh how the withdrawals interact, which is why an in-person assessment matters more, not less.

Yes, often it is the part that matters most. Alcohol withdrawal is one of the few that can itself be fatal, so daily drinking layered under an opioid or stimulant withdrawal can be the hidden danger. It is exactly the kind of use people forget to mention, and naming it lets a clinician gauge the real risk.

Yes. Prescriptions, alcohol, cannabis, and anything bought over the counter all change the withdrawal picture, and a clinician can only manage what they are told. A complete list is not a confession; it is the single most useful thing you can provide to stay safe. Leaving something off is how a combined withdrawal turns dangerous.

For polysubstance use that is a risky frame. Stopping everything at once removes any way to tell which withdrawal is causing which symptom, and for alcohol and sedatives an abrupt stop is the specific thing that can trigger a seizure. Combined withdrawal is a situation to manage with a medical assessment rather than alone.

FindTreatment.gov is the federal government's free, confidential locator of state-licensed treatment facilities, a neutral route rather than a marketing helpline. An in-person assessment can sort which substance carries the lethal risk and what setting fits. If withdrawal already involves a seizure, severe confusion, or thoughts of self-harm, that is an emergency.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

If things feel heavy, a person is available anytime — call or text 988.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When a combined withdrawal is an emergency

  • —A seizure during withdrawal, or a first-ever seizure of any kind
  • —Severe confusion, agitation, or seeing or hearing things that are not there, especially with fever and a racing heart
  • —Chest pain, a fast or irregular heartbeat, or trouble breathing while withdrawing
  • —Hopelessness or thoughts of suicide, which can surface as several substances leave the body at once

Call 911 or go to the nearest emergency room for a seizure, severe confusion, or chest pain. If there are thoughts of suicide, call or text 988 for the Suicide and Crisis Lifeline.

This article explains why withdrawing from more than one substance at once raises the medical risk. It is general information, not medical advice, and it gives no taper schedules or doses, because a safe plan is specific to the person and the full combination they use. Whether and how to stop is a decision for you and a licensed clinician who can evaluate you.

References

  1. 1.U.S. Food and Drug Administration (2020). Benzodiazepine Drug Class: Drug Safety Communication — Boxed Warning Updated to Improve Safe Use. U.S. Food and Drug Administration (FDA). link ✓That benzodiazepine dependence can develop even with as-prescribed use, and that abrupt discontinuation or too-rapid dose reduction can cause life-threatening withdrawal including seizures, so a gradual patient-specific taper is required.
  2. 2.Centers for Disease Control and Prevention (2024). Facts About U.S. Deaths from Excessive Alcohol Use. CDC Alcohol Use. linkThat excessive alcohol use is responsible for roughly 178,000 U.S. deaths each year, establishing alcohol as one of the deadliest substances by population impact.
  3. 3.National Institute on Drug Abuse (2024). Co-Occurring Disorders and Health Conditions. National Institute on Drug Abuse (NIDA), NIH. link ✓That substance use disorders and other mental illnesses frequently co-occur and that treatment should address both conditions concurrently rather than sequentially.
  4. 4.Lee JD, Nunes EV, Novo P, et al. (2018). Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial. The Lancet. doi:10.1016/S0140-6736(17)32812-X ✓That extended-release naltrexone is harder to initiate than buprenorphine-naloxone because it requires completed detox first, causing more early induction failures, but once successfully started both were similarly safe and effective.
  5. 5.National Institute on Drug Abuse (2024). Medications for Opioid Use Disorder. National Institute on Drug Abuse (NIDA), NIH. link ✓That medications for opioid use disorder are an evidence-based standard of care and that methadone or buprenorphine reduce cravings and withdrawal without producing a high at therapeutic doses, so treatment is not substituting one addiction for another.
  6. 6.Substance Abuse and Mental Health Services Administration (2024). FindTreatment.gov. SAMHSA. link ✓That FindTreatment.gov is the federal government's free, confidential, anonymous locator of state-licensed treatment facilities for mental and substance use disorders.

6 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy

← Back to the health library